Operil

Operil belongs to Sandoz Group AG through Lek farmacevtska družba d.d.. Operil is owned by Sandoz Group AG, headquartered in Switzerland. No. The ultimate owner of Operil, Sandoz Group AG, is headquartered in Switzerland, not in the United States.

Sandoz Pharmaceuticals is a global leader in generic pharmaceuticals and biosimilars, offering a broad portfolio of high-quality medicines.

Lek Pharmaceuticals